CD163 and cancer: By contrast, the observation that higher numbers of CD163 positive macrophages and CD54+ microvessels were both associated with better survival of RME patients was unexpected: In almost all cancers high numbers of macrophages herald a poor prognosis that is thought to reflect the role of macrophages as suppressors of antitumor immunity and promoters of invasion and metastasis48.